ROCHE HOLDING AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 240 CHF | +1.35% |
|
+0.84% | -8.19% |
| 26/04 | Roche: positive CHMP opinion for Alecensa | CF |
| 26/04 | Roche’s Lung Cancer Drug Alecensa Backed for Approval in EU | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 250.20 | 273.80 | 272.20 |
| Spread/Res. | -4.08% | -12.34% | -11.83% |
| Spread/Supp. | +3.63% | +3.63% | +3.63% |
| Support | 231.60 | 231.60 | 231.60 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ROG Stock
- RO Stock
- Charts Roche Holding AG
